Expression of the intermediate filament peripherin in extraskeletal myxoid chondrosarcoma

Journal of Cutaneous Pathology

Volumn 27, Issue 3, 2000, Pages 141-146

  Cummings, Thomas J ^a   Shea, Christopher R ^a   Reed, Jon A ^b   Burchette, James L ^a   Prieto, Victor G ^a,c  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DIFFERENTIATION ANTIGEN; PERIPHERIN;

ADOLESCENT; ADULT; AGED; ALVEOLAR SOFT PART SARCOMA; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CHONDROSARCOMA; CHROMOSOME 12; CLEAR CELL SARCOMA; CLINICAL ARTICLE; CYTOPLASM; EPITHELIOID SARCOMA; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; LIPOSARCOMA; MALE; MESODERM; MYXOSARCOMA; NERVE CELL; NERVE SHEATH TUMOR; NEURAL CREST; NEURAL TUBE; NEUROSECRETORY CELL; PROTEIN EXPRESSION; SOFT TISSUE TUMOR;

ADOLESCENT; AGED; BIOLOGICAL MARKERS; CHONDROSARCOMA; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENT PROTEINS; LIPOSARCOMA; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; NERVE TISSUE PROTEINS; SARCOMA, ALVEOLAR SOFT PART; SARCOMA, CLEAR CELL; SOFT TISSUE NEOPLASMS;

EID: 0034001910     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0560.2000.027003141.x     Document Type: Article

References (45)

1. 1. Portier MM, de Nechaud B. Peripherin, a new member of the intermediate filament protein family. Dev Neurosci 1983/84; 6: 335.
2. 2. Moncla A, Landon F, Mattei MG, Portier MM. Chromosomal localisation of the mouse and human peripherin genes. Genet Res 1992; 59: 125.
3. 3. Escurat M, Djabali K, Gumpel M, Gros F, Portier MM. Differential expression of two neuronal intermediate filament proteins, peripherin and the low molecular mass neurofilament protein (NF-L), during the development of the rat. J Neurosci 1990; 10: 764.
4. 4. Portier MM, Escurat M, Landon F, Djabali K, Bousquet O. Peripherin and neurofilaments: expression and role during neural development. C. R. Acad. Sci. Paris, Sciences de la vie/ Life sciences 1993; 316: 1133.
5. 5. Prieto VG, Slavik T, Reed JA, Burchette JL, Shea CR. Expression of the intermediate filament protein peripherin in fetal melanocytes. J Cutan Pathol 1998; 25: 509a.
6. 6. Prieto VG, McNutt NS, Lugo J, Reed JA. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1997; 24: 145.
7. 7. Prieto VG, McNutt NS, Lugo J, Reed JA. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi. Am J Surg Pathol 1997; 21: 1450.
8. 8. Wong J, Oblinger MM. Differential regulation of peripherin and neurofilament gene expression in regenerating rat DRG neurons. J Neurosci Res 1990; 27: 332.
9. 9. Pedersen WA, Becker LE, Yeger H. Expression and distribution of peripherin protein in human neuroblastoma cell lines. Int J Cancer 1993; 53: 463.
10. 10. Baudoin C, Meneguzzi G, Portier MM, et al. Peripherin, a neuronal intermediate protein, is stably expressed by neuroendocrine carcinomas of the skin, their xenograft on nude mice, and the corresponding primary cultures. Cancer Res 1993; 53: 1175.
11. 11. Tallini G, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing (A report from the CHAMP group). Am J Surg Pathol 1996; 20: 1047.
12. 12. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nat Genet 1993; 4: 341.
13. 13. Baker CVH, Bronner-Fraser M, Le Douarin NM, Teillet MA. Early and late-migrating cranial neural crest populations have equivalent developmental potential in vivo. Development 1997; 124: 3077.
14. 14. Stefansson K, Wollman RL, Moore BW, Arnason BGW S-100 protein in human chondrocytes. Nature 1982; 295: 63.
15. 15. Egerbacher M, Krestan R, Bock P. Morphology, histochemistry, and differentiation of the cat's epiglottic cartilage: a supporting organ composed of elastic cartilage, fibrous cartilage, myxoid tissue, and fat tissue. Anat Rec 1995; 242: 471.
16. 16. Hall BK. Chondrogenesis of the somitic mesoderm. Adv Anat Embryol Cell Biol 1978; 53: 1.
17. 17. McNutt NS. The S-100 family of multipurpose calcium-binding proteins. J Cutan Pathol 1998; 25: 521.
18. 18. Cocchia D, Lauriola L, Stolfi VM, Tallini G, Michetti F. S-100 antigen labels neoplastic cells in liposarcoma and cartilaginous tumours. Virchows Arch [Pathol Anat] 1983; 402: 139.
19. 19. Nakajima T, Watanabe S, Sato Y, Kameya T, Hirota T, Shimosato Y. An immunoperoxidase study of S-100 protein distribution in normal and neoplastic tissues. Am J Surg Pathol 1982; 6: 715.
20. 20. Weiss APC, Dorfman HD. S-100 protein in human cartilage lesions. J Bone Joint Surg 1986; 68A: 521.
21. 21. Dei Tos AP, Wadden C, Fletcher CDM. Extraskeletal myxoid chondrosarcoma: an immunohistochemical reappraisal of 39 cases. Appl Immunohistochem 1997; 5: 73.
22. 22. Meis-Kindblom JM, Bergh P, Gunterberg B, Kindblom LG. Extraskeletal myxoid chondrosarcoma. A reappraisal of its morphologic spectrum and prognostic factors based on 117 cases. Am J Surg Pathol 1999; 23: 636.
23. 23. Stout AP, Verner EW. Chondrosarcoma of the extraskeletal soft tissues. Cancer 1953; 6: 581.
24. 24. Enzinger FM, Shiraki M. Extraskeletal myxoid chondrosarcoma. An analysis of 34 cases. Hum Pathol 1972; 3: 421.
25. 25. Vuzevski VD, van der Heul RO. Comparative ultrastructure of soft-tissue myxoid tumors. Ultrastruct Pathol 1988; 12: 87.
26. 26. Antonescu CR, Argani P, Erlandson RA, Healey JH, Ladanyi M, Huvos AG. Skeletal and extraskeletal myxoid chondrosarcoma. A comparative clinicopathologic, ultrastructural, and molecular study. Cancer 1998; 83: 1504.
27. 27. Sciot R, Dal Cin P, Fletcher C, et al. t(9;22)(q22 31 ;q11 12) is a consistent marker of extraskeletal myxoid chondrosarcoma: evaluation of three cases. Mod Pathol 1995; 8: 765.
28. 28. Chhieng DC, Erlandson RA, Antonescu C, Ladanyi M, Rosai J. Neuroendocrine differentiation in adult soft tissue sarcomas with features of extraskeletal myxoid chondrasarcoma: report of seven cases. Lab Invest 1998; 78: 80.
29. 29. Schmidt D, Harms D. Epithelioid sarcoma in children and adolescents. An immunohistochemical study. Virchows Arch A 1987; 410: 423.
30. 30. Gerharz CD, Moll R, Meister P, Knuth A, Gabbert H. Cytoskeletal heterogeneity of an epithelioid sarcoma with expression of vimentin, cytokeratins and neurofilaments. Am J Surg Pathol 1990; 14: 274.
31. 31. Auerbach HE, Brooks JJ. Alveolar soft part sarcoma. A clinicopathologic and immunohistochemical study. Cancer 1987; 60: 66.
32. 32. Mathew T. Evidence supporting neural crest origin of an alveolar soft part sarcoma. An ultrastructural study. Cancer 1982; 50: 507.
33. 33. Napolitano L. The differentiation of white adipose cells. An electron microscope study. J Cell Biol 1963; 663.
34. 34. Michetti F, Dell'Anna E, Tiberio G, Cocchia D. Immunohistochemical and immunocytochemical study of S-100 protein in rat adipocytes. Brain Res 1983; 262: 352.
35. 35. Mentzel T, Fletcher CDM. Recent advances in soft tissue tumor diagnosis. Am J Clin Pathol 1998; 110: 660.
36. 36. Gibas Z, Miettinen M, Limon J, et al. Cytogenetic and immunohistochemical profile of myxoid liposarcoma. Am J Clin Pathol 1995; 103: 20.
37. 37. Rosai J, Akerman M, Dal Cin P, et al. Combined morphologic and karyotypic study of 59 atypical lipomatous tumors. Evaluation of their relationship and differential diagnosis with other adipose tissue tumors. (A report from the CHAMP group). Am J Surg Pathol 1996; 20: 1182.
38. 38. Husain S, Silvers DN, Halperin AJ, McNutt NS. Histologic spectrum of neurothekeoma and the value of immunoperoxidase staining for S-100 protein in distinguishing it from melanoma. Am J Dermatopathol 1994; 16: 496.
39. 39. Barnhill RL, Mihm MC. Jr. Cellular neurothekeoma. A distinct variant of neurothekeoma mimicking nevomelanocytic tumors. Am J Surg Pathol 1990; 14: 113.
40. 40. Gallager RL, Helwig EB. Neurothekeoma. A benign cutaneous tumor of neural origin. Am J Clin Pathol 1980; 74: 759.
41. 41. Angervall L, Kindblom LG, Haglid K. Dermal nerve sheath myxoma a light and electron microscopic, histochemical and immunohistochemical study. Cancer 1984; 53: 1752.
42. 42. Busam KJ, Mentzel T, Colpaert C, Barnhill RL, Fletcher CDM. Atypical or worrisome features in cellular neurothekeoma. A study of 10 cases. Am J Surg Pathol 1998; 22: 1067.
43. 43. Chung EB, Enzinger FM. Malignant melanoma of soft parts: a reassessment of clear cell sarcoma. Am J Surg Pathol 1983; 7: 405.
44. 44. Ohno T, Park P, Utsunomiya Y, Hirahata H, Inoue K. Ultra-structural study of a clear cell sarcoma suggesting schwannian differentiation. Ultrastruct Pathol 1986; 10: 39.
45. 45. Benson JD, Kraemer B, Mackay BB. Malignant melanoma of soft parts: an ultrastructural study of four cases. Ultrastruct Pathol 1985; 8: 57.